相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes
Jie Li et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Preliminary predictive criteria for COVID-19 cytokine storm
Roberto Caricchio et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Haemophagocytic syndrome and COVID-19
Soledad Retamozo et al.
CLINICAL RHEUMATOLOGY (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It
Stefano Cappanera et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Evdoxia Kyriazopoulou et al.
NATURE MEDICINE (2021)
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
Roberto Littera et al.
PLOS ONE (2021)
Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis
Laura Vinas-Gimenez et al.
FRONTIERS IN IMMUNOLOGY (2021)
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Esraa M. Eloseily et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management
Lauren A. Henderson et al.
PEDIATRIC DRUGS (2020)
Cardiovascular complications in COVID-19
Brit Long et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)
The genetics of macrophage activation syndrome
Grant S. Schulert et al.
GENES AND IMMUNITY (2020)
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Lauren A. Henderson et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Secondary HLH is uncommon in severe COVID-19
Henry Wood et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis
Jonathan Feld et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19
Giuseppe G. Loscocco et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Cardiac complications in patients hospitalised with COVID-19
Marijke Linschoten et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
Brandon J. Webb et al.
LANCET RHEUMATOLOGY (2020)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza
Grant S. Schulert et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis
Mingce Zhang et al.
JOURNAL OF IMMUNOLOGY (2016)
Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion
Waldo A. Spessott et al.
BLOOD (2015)
Genetic Defects in Cytolysis in Macrophage Activation Syndrome
Mingce Zhang et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
Laurence Fardet et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Reaching the Threshold: A Multilayer Pathogenesis of Macrophage Activation Syndrome
Raffaele Strippoli et al.
JOURNAL OF RHEUMATOLOGY (2013)
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes
Yenan T. Bryceson et al.
BLOOD (2012)
Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11
Udo zur Stadt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells
Marjorie Cote et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter
Masayuki Endo et al.
MOLECULAR THERAPY (2008)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
分享论文
